Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Vectorite Biomedical, Inc. (4170) Income Statement

Vectorite Biomedical, Inc. Income Statement

Last quarter (Q2 2026), Vectorite Biomedical, Inc.'s total revenue was NT$27.13M, an increase of 14.95% from the same quarter last year. In Q2, Vectorite Biomedical, Inc.'s net income was NT$25.88M. See Vectorite Biomedical, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
NT$ 61.41MNT$ 57.77MNT$ 55.85MNT$ 42.91MNT$ 28.77M
NT$ 21.68MNT$ 16.97MNT$ 16.42MNT$ 707.00KNT$ -2.47M
NT$ 43.59MNT$ 42.94MNT$ 32.55MNT$ 31.24MNT$ 39.93M
Depreciation and AmortizationNT$ 8.14MNT$ 8.76MNT$ 9.16MNT$ 8.86MNT$ 16.51M
NT$ -13.77MNT$ -17.21MNT$ -6.97MNT$ -21.68MNT$ -25.94M
NT$ -21.91MNT$ -25.97MNT$ -16.13MNT$ 30.54MNT$ -42.39M
NT$ 118.05MNT$ -14.10MNT$ 9.50MNT$ 4.08MNT$ 50.76M
NT$ 96.14MNT$ -40.07MNT$ -6.63MNT$ -26.45MNT$ 8.33M
NT$ 96.14MNT$ -40.05MNT$ -6.60MNT$ -26.41MNT$ 8.36M
Per Share Metrics
Basic EPSNT$ 2.20NT$ -0.92NT$ -0.15NT$ -0.60NT$ 0.23
Diluted EPSNT$ 2.20NT$ -0.92NT$ -0.15NT$ -0.60NT$ 0.23
Weighted Average Shares Outstanding43.70M43.71M43.77M43.77M36.45M
Weighted Average Shares Outstanding (Diluted)43.70M43.71M43.77M43.77M36.50M

Currency in TWD

Vectorite Biomedical, Inc. Earnings and Revenue History

-120M0120M240M-400 %-200 %0 %200 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin